An Open-Label Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Latest Information Update: 07 Dec 2023
At a glance
- Drugs EscharEx (Primary)
- Indications Basal cell cancer
- Focus Adverse reactions
- Sponsors MediWound
- 20 Dec 2021 New trial record